Patient's question:
Multiple sclerosis (MS) is a clinical manifestation of central nervous system demyelination, characterized by diversity and susceptibility to interference from climate and other factors. It has a high incidence rate, tends to affect young people, and has a long course with potential to cause multi-system damage, ultimately leading to disability in patients and impairing quality of life. Therefore, overcoming this challenge has become a focal point of worldwide research. What are the current drugs for multiple sclerosis?Doctor's answer:
The "special treatment for outpatients with malignant tumors" project, which includes outpatient chemotherapy, radiotherapy, and other treatments for malignant tumors, has been slightly adjusted to enhance the inclusion of biological targeted drug treatment. Specifically, the "biological targeted drug treatment, radiotherapy, and the configuration treatment during their course" for patients with malignant tumors in secondary and tertiary designated medical institutions, has had its entry criteria adjusted from "requiring the implementation of chemotherapy and radiotherapy" to "requiring the implementation of chemotherapy (including biological targeted drug treatment) and radiotherapy."